Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00558831 · ClinicalTrials.gov registry record · NA

Study of Benzoyl Peroxide Cream for Mild to Moderate Acne Vulgaris

A NA study of Acne Vulgaris, sponsored by Northwestern University.

Completed
Registry status
NA
Development phase
11
Enrollment target
1
Study location

NCT00558831: Completed NA study of Acne Vulgaris, sponsored by Northwestern University.

NCT00558831 is a NA study of Acne Vulgaris that has completed, run by Northwestern University. The registered enrollment target is 11 participants, below the 275-participant average among 67 other Acne Vulgaris trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00558831, a NA study of Acne Vulgaris, has completed, sponsored by Northwestern University.

COMPLETED
Registry status
NA
Development phase
11 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to compare the efficacy of a benzoyl peroxide 2.5% cream formulation plus a moisturizing lotion versus benzoyl peroxide 2.5% cream alone for the treatment of acne vulgaris.

Primary Outcome

-1=worse 0=unchanged * 1=mild improvement * 2=moderate improvement * 3=clear

Conditions Studied

Interventions

  • DRUG Benzoyl Peroxide
  • DRUG Moisturizing Lotion

Study Locations (1)

Illinois

  • Northwestern University Department of Dermatology - Chicago

Trial Details

FieldValue
Enrollment Target 11 participants
Start Date 2007-10
Est. Completion 2008-01
Phase NA
Northwestern University

1,209 total trials

What the finished NCT00558831 record still lists

NCT00558831 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 11 participants, a relatively small participant target, below the 275-participant average among 67 other Acne Vulgaris trials with a reported enrollment target (96% lower).

The record links to 1 condition, with Acne Vulgaris appearing as the primary indexed condition, and to 2 interventions - of which Benzoyl Peroxide is the first listed.

NCT00558831 reports a single indexed study location in Illinois.

Frequently Asked Questions

What is clinical trial NCT00558831 about?

NCT00558831 is a clinical study titled "Study of Benzoyl Peroxide Cream for Mild to Moderate Acne Vulgaris". The purpose of this study is to compare the efficacy of a benzoyl peroxide 2.5% cream formulation plus a moisturizing lotion versus benzoyl peroxide 2.5% cream alone for the treatment of acne vulgaris.

What is the current status of trial NCT00558831?

This trial is currently completed. It is a NA study. The enrollment target is 11 participants. The study started on 2007-10. Estimated completion is 2008-01.

What conditions does trial NCT00558831 study?

This clinical trial studies the following conditions: Acne Vulgaris.

What interventions are being tested in trial NCT00558831?

The interventions under investigation include: Benzoyl Peroxide (DRUG), Moisturizing Lotion (DRUG).

Who is sponsoring clinical trial NCT00558831?

This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00558831 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Acne Vulgaris

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00558831's enrollment target sits among peer trials

11 65th of 67 higher than 3 of 67 other Acne Vulgaris trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Acne Vulgaris trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03114462 · 11 participants · Phase 1

    Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer

  • NCT06039709 · 11 participants · Phase 1

    Sonodynamic Therapy in Patients With Recurrent GBM

  • NCT06425380 · 11 participants · NA

    Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy

  • NCT06472661 · 11 participants · Early Phase 1

    FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00558831, the US trial registry maintained by the National Library of Medicine. NCT00558831 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.